获得的非允许性BM微环境会影响HSC的增殖和维护以及HSCT后的B细胞发展
Melanie de Gier1, Jakov Korzhenevich2, Franziska Schmidt2
1LUMC, Leiden, Netherlands.
Blood advances
|January 16, 2026
概括
造血干细胞移植 (HSCT) 可以导致由于骨髓微环境缺陷而导致B细胞缺乏. 这项研究揭示了获得的,永久的B细胞损失与减少CXCL12在介质细胞 stromal细胞,损害HSC功能.
科学领域:
- 血液学 血液学 血液学
- 免疫学 免疫学 免疫学
- 干细胞生物学 干细胞生物学
背景情况:
- 血造干细胞移植 (HSCT) 后B细胞复合的缺陷很常见,但人们对其了解甚少.
- 骨髓 (BM) 微环境,包括介质干细胞 (MSCs),对于HSC维护和B-lymphopoiesis至关重要.
研究的目的:
- 调查BM微环境对X链接淋巴增殖性疾病患者在HSCT后B细胞复合中断的贡献.
- 为了识别潜在的机制,尽管完全的捐赠者虚拟现象,获得的,永久的B细胞缺乏.
主要方法:
- 从一个指标患者和他的同卵双胞胎与对比的HSCT结果的纵向BM样本分析.
- 在体外建模使用患者衍生的MSC和HSC.
- 大量RNA测序MSC和功能测试.
主要成果:
- 索引患者表现出HSC扩散的渐进性丧失和B前阶段的选择性阻断.
- 来自患者的MSCs显示对HSC和B细胞发育的支持受损,与减少的CXCL12水平相关.
- 观察到患者MSC的总体变化和CXCL12表达的逐渐丧失;CXCL12补充改善了HSC存活率.
结论:
- 在BM-stromal微环境中获得的缺陷,特别是MSCs减少的CXCL12表达,导致HSCT后永久的B细胞缺乏.
- HSC 疲和祖细胞缺陷为 B 细胞发育创造了一个不允许的状态.
相关概念视频
Regulation of Hematopoietic Stem Cells
4.0K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
4.0K
Bone Marrow Sampling and Transplants
899
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
899
Stem Cell Therapy for Tissue Regeneration
4.6K
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.6K
Multipotency of Hematopoietic Stem Cells
3.8K
The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...
3.8K
Cell-mediated Immune Responses
83.5K
Overview
83.5K
Immunodeficiency Diseases
2.0K
Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency...
There are three main causes of immunodeficiency...
2.0K


